Changing the world

UCLB is the commercialisation company of UCL. We bring to market truly world-leading, world-changing technologies and innovations that have a real and positive impact on people’s lives.

Find out more


UCLB - Big Talks on Big Impacts (Episode 3: Beating Cancer)

In the third episode of this podcast series, UCLB Director of BioPharm, Dr Richard Fagan, is in conversation with the co-founder of UCL spinout Achilles Therapeutics, Professor Charles Swanton. They discuss Achilles Tx’s achievements and how TRACERx, the first study to track the evolution of cancer cells, will help us beat cancer.

Read more News


Read more case studies